Anticardiolipin antibodies in ischaemic heart disease: marker or myth?. Issue 5 (May 1993)

• Record Type: Journal Article
• Authors: Phadke, K V; Phillips, R A; Clarke, D T; Jones, M; Naish, P; Carson, P
• Is Part Of: Heart. Volume 69:Issue 5(1993)
• Page Start: 391
• Page End: 394
• Publication Date: 1993-05
• Subjects: Heart -- Diseases -- Treatment -- Periodicals; Cardiology -- Periodicals; 616.12
• DOI: 10.1136/hrt.69.5.391
• Languages: English
• ISSNs: 1355-6037

Abstract

Abstract : OBJECTIVES--To assess the incidence and significance of anticardiolipin antibodies after myocardial infarction and in unstable angina. DESIGN--A prospective study of all patients under 60 admitted to the coronary care unit over a 12 month period with a diagnosis of acute myocardial infarction who were followed up for a further 12 months. Patients admitted with unstable angina were similarly assessed but not followed up. Anticardiolipin antibody concentrations were compared with those of age matched controls. SETTING--A district general hospital. PATIENTS--307 patients with acute myocardial infarction and 160 patients with unstable angina. RESULTS--Anticardiolipin antibody concentrations in the two patient groups did not differ significantly from those in the control groups. Antibody concentrations were not related to a history of angina or myocardial infarction nor were they related to subsequent cardiovascular complications. CONCLUSION--This study shows no significant association between anticardiolipin antibody concentrations and either myocardial infarction or unstable angina.